artifact removal software Search Results


automated projection-artifact removal software  (SVision LLC)
90
SVision LLC automated projection-artifact removal software
Automated Projection Artifact Removal Software, supplied by SVision LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/automated projection-artifact removal software/product/SVision LLC
Average 90 stars, based on 1 article reviews
automated projection-artifact removal software - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
artifact removal software  (Compumedics Neuroscan)
90
Compumedics Neuroscan artifact removal software
Artifact Removal Software, supplied by Compumedics Neuroscan, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/artifact removal software/product/Compumedics Neuroscan
Average 90 stars, based on 1 article reviews
artifact removal software - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
3d projection artifact removal (par) software par-octa  (SVision LLC)
90
SVision LLC 3d projection artifact removal (par) software par-octa
3d Projection Artifact Removal (Par) Software Par Octa, supplied by SVision LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/3d projection artifact removal (par) software par-octa/product/SVision LLC
Average 90 stars, based on 1 article reviews
3d projection artifact removal (par) software par-octa - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
3-d projection artifact removal software (parocta)  (Optovue)
90
Optovue 3-d projection artifact removal software (parocta)
Identifying differences in the deep capillary plexus (DCP) between projection artifact removal <t>(PAROCTA)</t> and non-PAROCTA processed eyes. ( A, B ) Binarized images of the DCP using PAROCTA and non-PAROCTA versions of the software. ( C ) Pixels exclusive to PAROCTA obtained by subtracting the non-PAROCTA image from the PAROCTA image. ( D ) Pixels exclusive to non-PAROCTA obtained by subtracting the PAROCTA image from the non-PAROCTA image. ( E , F ) Pixels unique to each version of the software (green) overlaid on the superficial capillary plexus (SCP) (Red) with common pixels shown in yellow, demonstrating that differences unique to non-PAROCTA are mainly projection artifacts from the SCP while those exclusive from PAROCTA originate from the DCP. ( G ) Pixels unique to PAROCTA (green) when overlaid on the non-PAROCTA DCP (red) demonstrate “recovery” of finer capillaries not previously visualized on non-PAROCTA.
3 D Projection Artifact Removal Software (Parocta), supplied by Optovue, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/3-d projection artifact removal software (parocta)/product/Optovue
Average 90 stars, based on 1 article reviews
3-d projection artifact removal software (parocta) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
projection artifact removal software par-octa  (Optovue)
90
Optovue projection artifact removal software par-octa
Spectral domain-OCT (SD-OCT), <t>projection</t> <t>artifact</t> <t>removal</t> (PAR) OCTA (Optovue, Inc.) and PR-OCTA scans at thresholds of 0.5, 0.7 and 1.0 of the same eye in . The RAP lesion (yellow circle) shows persistent flow signal despite increasing PR-OCTA thresholds. Red pixel percentage decreased between PR-OCTA thresholds 0.5, 0.7 and 1.0 from 42.5% to 39.9% then 37.7%, but remained higher at 1.0 than green and blue pixels (30.9% and 31.3%, respectively).
Projection Artifact Removal Software Par Octa, supplied by Optovue, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/projection artifact removal software par-octa/product/Optovue
Average 90 stars, based on 1 article reviews
projection artifact removal software par-octa - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
artifact remove neuroscan software  (Compumedics Neuroscan)
90
Compumedics Neuroscan artifact remove neuroscan software
Spectral domain-OCT (SD-OCT), <t>projection</t> <t>artifact</t> <t>removal</t> (PAR) OCTA (Optovue, Inc.) and PR-OCTA scans at thresholds of 0.5, 0.7 and 1.0 of the same eye in . The RAP lesion (yellow circle) shows persistent flow signal despite increasing PR-OCTA thresholds. Red pixel percentage decreased between PR-OCTA thresholds 0.5, 0.7 and 1.0 from 42.5% to 39.9% then 37.7%, but remained higher at 1.0 than green and blue pixels (30.9% and 31.3%, respectively).
Artifact Remove Neuroscan Software, supplied by Compumedics Neuroscan, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/artifact remove neuroscan software/product/Compumedics Neuroscan
Average 90 stars, based on 1 article reviews
artifact remove neuroscan software - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
artifact detection and removal function of the neuroguide deluxe software v. 2.3.7  (Applied Neuroscience Inc)
90
Applied Neuroscience Inc artifact detection and removal function of the neuroguide deluxe software v. 2.3.7
Spectral domain-OCT (SD-OCT), <t>projection</t> <t>artifact</t> <t>removal</t> (PAR) OCTA (Optovue, Inc.) and PR-OCTA scans at thresholds of 0.5, 0.7 and 1.0 of the same eye in . The RAP lesion (yellow circle) shows persistent flow signal despite increasing PR-OCTA thresholds. Red pixel percentage decreased between PR-OCTA thresholds 0.5, 0.7 and 1.0 from 42.5% to 39.9% then 37.7%, but remained higher at 1.0 than green and blue pixels (30.9% and 31.3%, respectively).
Artifact Detection And Removal Function Of The Neuroguide Deluxe Software V. 2.3.7, supplied by Applied Neuroscience Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/artifact detection and removal function of the neuroguide deluxe software v. 2.3.7/product/Applied Neuroscience Inc
Average 90 stars, based on 1 article reviews
artifact detection and removal function of the neuroguide deluxe software v. 2.3.7 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Identifying differences in the deep capillary plexus (DCP) between projection artifact removal (PAROCTA) and non-PAROCTA processed eyes. ( A, B ) Binarized images of the DCP using PAROCTA and non-PAROCTA versions of the software. ( C ) Pixels exclusive to PAROCTA obtained by subtracting the non-PAROCTA image from the PAROCTA image. ( D ) Pixels exclusive to non-PAROCTA obtained by subtracting the PAROCTA image from the non-PAROCTA image. ( E , F ) Pixels unique to each version of the software (green) overlaid on the superficial capillary plexus (SCP) (Red) with common pixels shown in yellow, demonstrating that differences unique to non-PAROCTA are mainly projection artifacts from the SCP while those exclusive from PAROCTA originate from the DCP. ( G ) Pixels unique to PAROCTA (green) when overlaid on the non-PAROCTA DCP (red) demonstrate “recovery” of finer capillaries not previously visualized on non-PAROCTA.

Journal: Translational Vision Science & Technology

Article Title: Optical Coherence Tomography Angiography Projection Artifact Removal: Impact on Capillary Density and Interaction with Diabetic Retinopathy Severity

doi: 10.1167/tvst.9.7.10

Figure Lengend Snippet: Identifying differences in the deep capillary plexus (DCP) between projection artifact removal (PAROCTA) and non-PAROCTA processed eyes. ( A, B ) Binarized images of the DCP using PAROCTA and non-PAROCTA versions of the software. ( C ) Pixels exclusive to PAROCTA obtained by subtracting the non-PAROCTA image from the PAROCTA image. ( D ) Pixels exclusive to non-PAROCTA obtained by subtracting the PAROCTA image from the non-PAROCTA image. ( E , F ) Pixels unique to each version of the software (green) overlaid on the superficial capillary plexus (SCP) (Red) with common pixels shown in yellow, demonstrating that differences unique to non-PAROCTA are mainly projection artifacts from the SCP while those exclusive from PAROCTA originate from the DCP. ( G ) Pixels unique to PAROCTA (green) when overlaid on the non-PAROCTA DCP (red) demonstrate “recovery” of finer capillaries not previously visualized on non-PAROCTA.

Article Snippet: Several strategies have been implemented to reduce the effects of projection artifacts, which range from slab removal to projection resolved OCTA (PR-OCTA)., Recently, Garrity et al. described the use of a novel 3-D projection artifact removal software (PAROCTA) currently available as part of the AngioVue software (RTvue XR Avanti; Optovue, Fremont, CA).

Techniques: Software

Comparison Between Manual non-PAROCTA and PAROCTA VD Measurements Across DR Severity

Journal: Translational Vision Science & Technology

Article Title: Optical Coherence Tomography Angiography Projection Artifact Removal: Impact on Capillary Density and Interaction with Diabetic Retinopathy Severity

doi: 10.1167/tvst.9.7.10

Figure Lengend Snippet: Comparison Between Manual non-PAROCTA and PAROCTA VD Measurements Across DR Severity

Article Snippet: Several strategies have been implemented to reduce the effects of projection artifacts, which range from slab removal to projection resolved OCTA (PR-OCTA)., Recently, Garrity et al. described the use of a novel 3-D projection artifact removal software (PAROCTA) currently available as part of the AngioVue software (RTvue XR Avanti; Optovue, Fremont, CA).

Techniques: Comparison

Differences between PAROCTA and non-PAROCTA vessel density measurements in superficial (SCP) and deep capillary plexus (DCP) across different DR severity levels.

Journal: Translational Vision Science & Technology

Article Title: Optical Coherence Tomography Angiography Projection Artifact Removal: Impact on Capillary Density and Interaction with Diabetic Retinopathy Severity

doi: 10.1167/tvst.9.7.10

Figure Lengend Snippet: Differences between PAROCTA and non-PAROCTA vessel density measurements in superficial (SCP) and deep capillary plexus (DCP) across different DR severity levels.

Article Snippet: Several strategies have been implemented to reduce the effects of projection artifacts, which range from slab removal to projection resolved OCTA (PR-OCTA)., Recently, Garrity et al. described the use of a novel 3-D projection artifact removal software (PAROCTA) currently available as part of the AngioVue software (RTvue XR Avanti; Optovue, Fremont, CA).

Techniques:

Bar graphs demonstrating the differences between PAROCTA and non-PAROCTA in different diabetic retinopathy (DR) severity levels. The upper row illustrates changes in the SCP demonstrating that with increasing DR severity levels vessel density (VD) and vessel length density (VLD) decreases in both versions of the software. PAROCTA measurements are lower for both the VD and VLD, with increasing disparity with higher DR severity levels. The lower row illustrates changes in the DCP demonstrating similar trends to the SCP. However, PAROCTA measurements are greater for both the VD and VLD, with greater disparity in milder DR.

Journal: Translational Vision Science & Technology

Article Title: Optical Coherence Tomography Angiography Projection Artifact Removal: Impact on Capillary Density and Interaction with Diabetic Retinopathy Severity

doi: 10.1167/tvst.9.7.10

Figure Lengend Snippet: Bar graphs demonstrating the differences between PAROCTA and non-PAROCTA in different diabetic retinopathy (DR) severity levels. The upper row illustrates changes in the SCP demonstrating that with increasing DR severity levels vessel density (VD) and vessel length density (VLD) decreases in both versions of the software. PAROCTA measurements are lower for both the VD and VLD, with increasing disparity with higher DR severity levels. The lower row illustrates changes in the DCP demonstrating similar trends to the SCP. However, PAROCTA measurements are greater for both the VD and VLD, with greater disparity in milder DR.

Article Snippet: Several strategies have been implemented to reduce the effects of projection artifacts, which range from slab removal to projection resolved OCTA (PR-OCTA)., Recently, Garrity et al. described the use of a novel 3-D projection artifact removal software (PAROCTA) currently available as part of the AngioVue software (RTvue XR Avanti; Optovue, Fremont, CA).

Techniques: Software

( A ) Figure illustrating differences in the superficial capillary plexus (SCP) and deep capillary plexus (DCP) between projection artifact removal optical coherence tomography angiography (PAROCTA) and non-PAROCTA in an eye with no DR. The SCP appears to have similar vessel density in both PAR and non-PAROCTA images. The DCP using non-PAROCTA has many projection artifacts ( blue arrowheads ) and appears less dense compared to the PAROCTA image. ( B ) Image showing the difference between projection artifact removal optical coherence tomography angiography (PAROCTA) and non-PAROCTA in an eye with proliferative diabetic retinopathy (PDR) showing decreased vessel density (VD) in the superficial capillary plexus (SCP) with similar VD in the deep capillary plexus (DCP). Due to a decrease in SCP VD, fewer projection artifacts ( blue arrowheads ) are visible in the DCP in this eye with PDR compared to the eye with no DR.

Journal: Translational Vision Science & Technology

Article Title: Optical Coherence Tomography Angiography Projection Artifact Removal: Impact on Capillary Density and Interaction with Diabetic Retinopathy Severity

doi: 10.1167/tvst.9.7.10

Figure Lengend Snippet: ( A ) Figure illustrating differences in the superficial capillary plexus (SCP) and deep capillary plexus (DCP) between projection artifact removal optical coherence tomography angiography (PAROCTA) and non-PAROCTA in an eye with no DR. The SCP appears to have similar vessel density in both PAR and non-PAROCTA images. The DCP using non-PAROCTA has many projection artifacts ( blue arrowheads ) and appears less dense compared to the PAROCTA image. ( B ) Image showing the difference between projection artifact removal optical coherence tomography angiography (PAROCTA) and non-PAROCTA in an eye with proliferative diabetic retinopathy (PDR) showing decreased vessel density (VD) in the superficial capillary plexus (SCP) with similar VD in the deep capillary plexus (DCP). Due to a decrease in SCP VD, fewer projection artifacts ( blue arrowheads ) are visible in the DCP in this eye with PDR compared to the eye with no DR.

Article Snippet: Several strategies have been implemented to reduce the effects of projection artifacts, which range from slab removal to projection resolved OCTA (PR-OCTA)., Recently, Garrity et al. described the use of a novel 3-D projection artifact removal software (PAROCTA) currently available as part of the AngioVue software (RTvue XR Avanti; Optovue, Fremont, CA).

Techniques: Tomography

Comparison Between PAROCTA and non-PAROCTA Vessel Density, Vessel Linear Density and Adjusted Flow Index in Full Thickness OCTA Slabs

Journal: Translational Vision Science & Technology

Article Title: Optical Coherence Tomography Angiography Projection Artifact Removal: Impact on Capillary Density and Interaction with Diabetic Retinopathy Severity

doi: 10.1167/tvst.9.7.10

Figure Lengend Snippet: Comparison Between PAROCTA and non-PAROCTA Vessel Density, Vessel Linear Density and Adjusted Flow Index in Full Thickness OCTA Slabs

Article Snippet: Several strategies have been implemented to reduce the effects of projection artifacts, which range from slab removal to projection resolved OCTA (PR-OCTA)., Recently, Garrity et al. described the use of a novel 3-D projection artifact removal software (PAROCTA) currently available as part of the AngioVue software (RTvue XR Avanti; Optovue, Fremont, CA).

Techniques: Comparison

Image demonstrating that pixels unique to projection artifact removal optical coherence tomography angiography (PAROCTA) (green) overlaid on the superficial capillary plexus (SCP) (red) for orientation, demonstrating that there are significantly greater differences in eyes with no diabetic retinopathy (DR) (left hand image) compared to eyes with proliferative diabetic retinopathy (PDR) (right hand image).

Journal: Translational Vision Science & Technology

Article Title: Optical Coherence Tomography Angiography Projection Artifact Removal: Impact on Capillary Density and Interaction with Diabetic Retinopathy Severity

doi: 10.1167/tvst.9.7.10

Figure Lengend Snippet: Image demonstrating that pixels unique to projection artifact removal optical coherence tomography angiography (PAROCTA) (green) overlaid on the superficial capillary plexus (SCP) (red) for orientation, demonstrating that there are significantly greater differences in eyes with no diabetic retinopathy (DR) (left hand image) compared to eyes with proliferative diabetic retinopathy (PDR) (right hand image).

Article Snippet: Several strategies have been implemented to reduce the effects of projection artifacts, which range from slab removal to projection resolved OCTA (PR-OCTA)., Recently, Garrity et al. described the use of a novel 3-D projection artifact removal software (PAROCTA) currently available as part of the AngioVue software (RTvue XR Avanti; Optovue, Fremont, CA).

Techniques: Tomography

Spectral domain-OCT (SD-OCT), projection artifact removal (PAR) OCTA (Optovue, Inc.) and PR-OCTA scans at thresholds of 0.5, 0.7 and 1.0 of the same eye in . The RAP lesion (yellow circle) shows persistent flow signal despite increasing PR-OCTA thresholds. Red pixel percentage decreased between PR-OCTA thresholds 0.5, 0.7 and 1.0 from 42.5% to 39.9% then 37.7%, but remained higher at 1.0 than green and blue pixels (30.9% and 31.3%, respectively).

Journal: PLoS ONE

Article Title: Projection resolved optical coherence tomography angiography to distinguish flow signal in retinal angiomatous proliferation from flow artifact

doi: 10.1371/journal.pone.0217109

Figure Lengend Snippet: Spectral domain-OCT (SD-OCT), projection artifact removal (PAR) OCTA (Optovue, Inc.) and PR-OCTA scans at thresholds of 0.5, 0.7 and 1.0 of the same eye in . The RAP lesion (yellow circle) shows persistent flow signal despite increasing PR-OCTA thresholds. Red pixel percentage decreased between PR-OCTA thresholds 0.5, 0.7 and 1.0 from 42.5% to 39.9% then 37.7%, but remained higher at 1.0 than green and blue pixels (30.9% and 31.3%, respectively).

Article Snippet: To investigate whether hyperreflective foci (HRF) exhibit flow projection artifact on OCTA, and study the efficacy of commercial projection artifact removal software (PAR-OCTA, Optovue, Inc), and a custom projection resolved OCTA (PR-OCTA) in distinguishing artifacts from true flow in retinal angiomatous proliferation (RAP).

Techniques:

Top row: Spectral domain-OCT (SD-OCT), projection artifact removal (PAR) OCTA and PR-OCTA scans at thresholds of 0.3, 0.5 and 0.7 of case 13. The flow artifact signal is seen in PAR-OCTA in the hard exudate (yellow ellipse). There is gradual decrease in the flow signal intensity with increasing PR-OCTA threshold from 0.3 to 0.5 (yellow ellipses), manifested by a decrease in red pixel percentage from 38.4% to 34.5%. The flow signal disappears at a threshold of 0.7 (cyan ellipse), where the red pixel percentage is equal to green and blue pixels (33% each), thus confirming it is projection artifact and not true flow. Bottom row: SD-OCT, PAR-OCTA and PR-OCTA scans at thresholds of 0.3, 0.5 and 0.7 of case 17. The flow artifact is seen in PAR-OCTA in the hard exudate (yellow circle). The flow artifact in this eye disappears at PR-OCTA threshold 0.5 (cyan circle) compared to 0.7 in the top row. The red pixel percentage drops from 35.9% in 0.3 to 33% in 0.5, to be equal to that of green and blue, confirming its disappearance.

Journal: PLoS ONE

Article Title: Projection resolved optical coherence tomography angiography to distinguish flow signal in retinal angiomatous proliferation from flow artifact

doi: 10.1371/journal.pone.0217109

Figure Lengend Snippet: Top row: Spectral domain-OCT (SD-OCT), projection artifact removal (PAR) OCTA and PR-OCTA scans at thresholds of 0.3, 0.5 and 0.7 of case 13. The flow artifact signal is seen in PAR-OCTA in the hard exudate (yellow ellipse). There is gradual decrease in the flow signal intensity with increasing PR-OCTA threshold from 0.3 to 0.5 (yellow ellipses), manifested by a decrease in red pixel percentage from 38.4% to 34.5%. The flow signal disappears at a threshold of 0.7 (cyan ellipse), where the red pixel percentage is equal to green and blue pixels (33% each), thus confirming it is projection artifact and not true flow. Bottom row: SD-OCT, PAR-OCTA and PR-OCTA scans at thresholds of 0.3, 0.5 and 0.7 of case 17. The flow artifact is seen in PAR-OCTA in the hard exudate (yellow circle). The flow artifact in this eye disappears at PR-OCTA threshold 0.5 (cyan circle) compared to 0.7 in the top row. The red pixel percentage drops from 35.9% in 0.3 to 33% in 0.5, to be equal to that of green and blue, confirming its disappearance.

Article Snippet: To investigate whether hyperreflective foci (HRF) exhibit flow projection artifact on OCTA, and study the efficacy of commercial projection artifact removal software (PAR-OCTA, Optovue, Inc), and a custom projection resolved OCTA (PR-OCTA) in distinguishing artifacts from true flow in retinal angiomatous proliferation (RAP).

Techniques:

Top row: Spectral domain OCT (SD-OCT), projection artifact removal (PAR) OCTA and PR-OCTA scans at thresholds of 0.3, 0.5 and 0.7 of case 6. The flow signal is seen in PAR-OCTA in the migratory RPE cells (yellow circle). There is gradual decrease in the flow signal intensity with increasing PR-OCTA threshold from 0.3 to 0.5 (yellow circles), manifested by a decrease in red pixel percentage from 36.2% to 34.3%. The flow signal disappears at 0.7 (cyan circle), where the red pixel percentage is equal to green and blue pixels (33% each), confirming it is projection artifact and not true flow. Bottom row: SD-OCT, PAR-OCTA and PR-OCTA scans at thresholds of 0.3, 0.5 and 0.7 of case 9. The flow artifact signal is seen in the HRF in PAR-OCTA (yellow circle). The flow artifact in this eye disappears at PR-OCTA threshold 0.5 (cyan circle) compared to 0.7 in the top row. The red pixel percentage drops from 34.7% in 0.3 to 33% in 0.5, to be equal to that of green and blue, confirming its disappearance.

Journal: PLoS ONE

Article Title: Projection resolved optical coherence tomography angiography to distinguish flow signal in retinal angiomatous proliferation from flow artifact

doi: 10.1371/journal.pone.0217109

Figure Lengend Snippet: Top row: Spectral domain OCT (SD-OCT), projection artifact removal (PAR) OCTA and PR-OCTA scans at thresholds of 0.3, 0.5 and 0.7 of case 6. The flow signal is seen in PAR-OCTA in the migratory RPE cells (yellow circle). There is gradual decrease in the flow signal intensity with increasing PR-OCTA threshold from 0.3 to 0.5 (yellow circles), manifested by a decrease in red pixel percentage from 36.2% to 34.3%. The flow signal disappears at 0.7 (cyan circle), where the red pixel percentage is equal to green and blue pixels (33% each), confirming it is projection artifact and not true flow. Bottom row: SD-OCT, PAR-OCTA and PR-OCTA scans at thresholds of 0.3, 0.5 and 0.7 of case 9. The flow artifact signal is seen in the HRF in PAR-OCTA (yellow circle). The flow artifact in this eye disappears at PR-OCTA threshold 0.5 (cyan circle) compared to 0.7 in the top row. The red pixel percentage drops from 34.7% in 0.3 to 33% in 0.5, to be equal to that of green and blue, confirming its disappearance.

Article Snippet: To investigate whether hyperreflective foci (HRF) exhibit flow projection artifact on OCTA, and study the efficacy of commercial projection artifact removal software (PAR-OCTA, Optovue, Inc), and a custom projection resolved OCTA (PR-OCTA) in distinguishing artifacts from true flow in retinal angiomatous proliferation (RAP).

Techniques: